Panacea Biotec Limited (PANACEABIO.BO)

INR 545.15

(-1.37%)

Total Liabilities Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual total liabilities in 2023 was 4.02 Billion INR , down -6.74% from previous year.
Panacea Biotec Limited's latest quarterly total liabilities in 2023 FY was 4.02 Billion INR , down -6.74% from previous quarter.
Panacea Biotec Limited reported annual total liabilities of 4.31 Billion INR in 2022, down -51.31% from previous year.
Panacea Biotec Limited reported annual total liabilities of 8.85 Billion INR in 2021, down -37.18% from previous year.
Panacea Biotec Limited reported quarterly total liabilities of - INR for 2023 Q1, down -100.0% from previous quarter.
Panacea Biotec Limited reported quarterly total liabilities of 4.02 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Total Liabilities of Panacea Biotec Limited (2023 - 2004)

Year	Total Liabilities	Total Liabilities Growth
2023	4.02 Billion INR	-6.74%
2022	4.31 Billion INR	-51.31%
2021	8.85 Billion INR	-37.18%
2020	14.09 Billion INR	17.97%
2019	11.94 Billion INR	16.19%
2018	10.28 Billion INR	-21.02%
2017	13.01 Billion INR	-9.21%
2016	14.33 Billion INR	3.37%
2015	13.87 Billion INR	-4.71%
2014	14.55 Billion INR	2.15%
2013	14.25 Billion INR	18.13%
2012	12.06 Billion INR	12.95%
2011	10.68 Billion INR	-1.7%
2010	10.86 Billion INR	10.85%
2009	9.8 Billion INR	-10.23%
2008	10.91 Billion INR	80.84%
2007	6.03 Billion INR	48.2%
2006	4.07 Billion INR	-46.73%
2005	7.64 Billion INR	195.24%
2004	2.59 Billion INR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 FY	4.02 Billion INR	-6.74%
2023 Q1	- INR	-100.0%
2023 Q4	4.02 Billion INR	0.0%
2023 Q2	4.28 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	5.45 Billion INR	0.0%
2022 Q4	4.31 Billion INR	0.0%
2022 FY	4.31 Billion INR	-51.31%
2021 Q3	- INR	-100.0%
2021 FY	8.85 Billion INR	-37.18%
2021 Q4	8.85 Billion INR	0.0%
2021 Q2	15.89 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q2	12.77 Billion INR	0.0%
2020 Q4	14.09 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	14.09 Billion INR	17.97%
2020 Q3	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 FY	11.94 Billion INR	16.19%
2019 Q1	- INR	-100.0%
2019 Q2	11.49 Billion INR	0.0%
2019 Q4	11.94 Billion INR	0.0%
2018 Q4	10.28 Billion INR	0.0%
2018 FY	10.28 Billion INR	-21.02%
2017 FY	13.01 Billion INR	-9.21%
2016 FY	14.33 Billion INR	3.37%
2015 FY	13.87 Billion INR	-4.71%
2014 FY	14.55 Billion INR	2.15%
2013 FY	14.25 Billion INR	18.13%
2012 FY	12.06 Billion INR	12.95%
2011 FY	10.68 Billion INR	-1.7%
2010 FY	10.86 Billion INR	10.85%
2009 FY	9.8 Billion INR	-10.23%
2008 FY	10.91 Billion INR	80.84%
2007 FY	6.03 Billion INR	48.2%
2006 FY	4.07 Billion INR	-46.73%
2005 FY	7.64 Billion INR	195.24%
2004 FY	2.59 Billion INR	0.0%

Peer Total Liabilities Comparison of Panacea Biotec Limited

Name	Total Liabilities	Total Liabilities Difference
Alfavision Overseas (India) Limited	1.36 Billion INR	-194.325%
Biocon Limited	307.95 Billion INR	98.695%
Blue Jet Healthcare Limited	2.13 Billion INR	-88.191%
Concord Biotech Limited	1.74 Billion INR	-130.962%
Dishman Carbogen Amcis Limited	39.53 Billion INR	89.832%
FERMENTA BIOTECH LIMITED	2.62 Billion INR	-53.053%
GENOMIC VALLEY BIOTECH LIMITED	7.91 Million INR	-50684.961%
Lyka Labs Limited	884.58 Million INR	-354.472%
SAMSRITA LABS LIMITED	32.93 Million INR	-12106.467%
Servoteach Industries Limited	5275.00 INR	-76212222.275%
SMS Lifesciences India Limited	1.96 Billion INR	-104.193%
Supriya Lifescience Limited	1.05 Billion INR	-279.73%
Syngene International Limited	18.93 Billion INR	78.773%
TAKE Solutions Limited	969.78 Million INR	-314.548%
Titan Biotech Limited	231.28 Million INR	-1638.187%
Transgene Biotek Limited	393.11 Million INR	-922.663%
Vanta Bioscience Limited	724.23 Million INR	-455.096%